Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study

Florence Duffaud; Jean Yves Blay; Axel Le Cesne; Christine Chevreau; Pascaline Boudou‐Rouquette; Elsa Kalbacher; Nicolas Penel; Christophe Perrin; Valérie Laurence; Emmanuelle Bompas; Esma Saâda-Bouzid; Corinne Delcambre; François Bertucci; Mathilde Cancel; Camille Schiffler; Laure Monard; Corinne Bouvier; Vincent Vidal; Nathalie Gaspar; Sylvie Chabaud

doi:10.1038/s41416-023-02413-9

Related publications

Article2023

Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study

Axel Le Cesne, Christine Chevreau, Christophe Perrin, Antoîne Italiano, Alice Hervieu, Jean Yves Blay, Sophie Piperno‐Neumann, Esma Saâda-Bouzid, François Bertucci, Nelly Firmin, Elsa Kalbacher, B. Narciso, Camille Schiffler, Sabrina Yara, Marta Jimenez, Corinne Bouvier, Vincent Vidal, Sylvie Chabaud, Florence Duffaud

Article2025

Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study

David Kavanagh, Andrew S. Bomback, Marina Vivarelli, Carla Nester, Giuseppe Remuzzi, Ming Zhao, Edwin Wong, Yaqin Wang, Ipsita Krishnan, Imelda Schuhmann, Angelo J. Trapani, Nicholas J.A. Webb, Matthias Meier, Rubeen Israni, Richard J. Smith, A Ramos Espinosa, Rita Marcela Fortunato, Mari Mar Freijo, Nadia Viviana Fretes, Pablo Raffaele, Gianna Mastroianni Kirsztajn, Juliana Mansur Siliano,

Article2019

Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial

Mark T. Drayson, Stella Bowcock, Tim Planche, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Jill Wood, Kerry Raynes, Helen Higgins, Bryony Dawkins, David Meads, Claire Hulme, Irene M. Monahan, Kamaraj Karunanithi, Helen Dignum, Edward Belsham, Jeff Neilson, Beth Harrison, Anand Lokare, Gavin Campbell, Michael R Hamblin, Peter M. Hawkey, ,

Article2020

Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial

Jean Yves Blay, César Serrano, Michael C. Heinrich, John Zalcberg, Sebastian Bauer, Hans Gelderblom, Patrick Schöffski, Robin L. Jones, Steven Attia, Gina Z. D’Amato, Ping Chi, Peter Reichardt, Julie Meade, Kelvin Shi, Rodrigo Ruiz‐Soto, Suzanne George, Margaret von Mehren

Article2016

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

Jordi Bruix, Shukui Qin, Philippe Merle, Alessandro Granito, Yi‐Hsiang Huang, G. Bodoky, Marc Pracht, Osamu Yokosuka, Olivier Rosmorduc, В. В. Бредер, René Gérolami, Gianluca Masi, Paul J. Ross, Tianqiang Song, Jean-Pierre Bronowicki, Isabelle Ollivier‐Hourmand, Masatoshi Kudo, Ann‐Lii Cheng, Josep M. Llovet, Richard S. Finn, Marie-Aude LeBerre, ,